there is -increasing evidence that acute virus Infection can result in self-perpetuating myocardial disease possibly mediated by T-Iymphocytes (Wong et al. 1977) .
Interest in pathogenetic mechanisms in polymyositis has been stimulated by observations of lymphocyte-mediated myotoxicityin patients with active disease. A recently developed technique, employing tritium-labelled carnitine as a selective marker for myotubes in a 'target' monolayer culture from fetal musclecells (Cambridge& Stern 1981) , represents an interesting development of these studies which might eventually prove applicable to clinical monitoring. On present evidence, virus-triggered lymphocyte-mediated pathogenesis appears the most attractive hypothesis.
John R Sewell 
Increased risk of lymphoma in dermatitis herpetiformis 1
There is a traditional link between certain skin disorders and underlying internal malignancy. However, with the passage of time, many of these associations have been shown to be fortuitous, often being related to the patient's age rather than any specific predisposition (e.g. bullous pemphigoid). However, coeliac disease (CD) is associated with an increased risk of developing lymphomas and other malignancies. The bullous skin disease dermatitis herpetiformis (DH) is associated with an underlying gluten-sensitive IArising from case presentation to Section of Dermatology, 21 May 198t 0141-0768/83/020095-03/$01.00/0 Cambridge G & Stern C (1981) Clinical and Experimental Immunology 43,211-219 Carpenter J, Bunch T, Engle A et al, (1977) enteropathy of varying severity, and it has been shown that the rash as well as the intestinal lesions are gluten dependent (Fryet al. 1973) . A strict gluten-free diet (GFD) will clear the rash and reverse the enteropathy. There are a number of case reports of the occurrence of lymphomas in DH. and in view of the similarity to coeliac disease it is important to know whether there is an increased risk of lymphomas and other malignancies in DH. Clinics for patients with CD are held in a number of centres and some were established over 20 years ago, so the association and incidence of malignancies is now becoming established. However, the association of DH and gluten-sensitive enteropathy only became recognized in 1968 (Fry et al. 1968 ) and there are very few centres which have followed up large numbers of DH patients for any length of time.
Since 1969 a dermatitis herpetiformis clinic has been held at St Mary's Hospital, London, and during this period 109 patients with DH have been seen (Leonard et al. 1983) . Only patients with IgA deposits in the dermal papillae of uninvolved skin were included in the study to determine the incidence of malignancy. Seven of the 109 patients have developed malignancies, 3 of these being lymphomas. All 3 would have formerly been called reticulum cell sarcomas. Only lymphoma, an immunoblastic sarcoma, proved fatal; at postmortem there was no evidence of bowel involvement. A second patient had a centroblastic lymphoma, and the third had malignant histiocytosis of the small intestine. The latter was the only patient with symptoms referable to his bowels. Of the other 2 patients, one presented with dyspnoea due to a pleural effusion, and the other with a hoarse voice due to involvement of the trachea and larynx. Among the 109 patients 3 malignancies would have been 'expected' to occur during this period, so it seems clear that the overall increase is largely due to the 3 lymphomas, the other tumours being 3 carcinomas of the lung, and a somatostatinoma of the small bowel. The 3 lymphomas in fact represented a 100-fold increase over the expected incidence of 0.03 for this type of tumour.
These results in DH are similar to the increased incidence of lymphoma in CD. Holmes et al. (1978) , who studied 202 patients with CD over the same length of time (12 years), found 4 patients who developed lymphomas. It should be stressed that the lymphoma does not always present as an intestinal lesion. Those that do begin in the intestine are now classified as malignant histiocytosis, and it has been suggested that this condition is distinct from the lymphomas which begin outside the gastrointestinal tract in CD and DH.
It is now well established that only approximately two-thirds of patients with DH have a macroscopic abnormality of the jejunal mucosa. In our 109 patients, 60 had this abnormality and 6 of the 7 malignancies occurred in this group. Thus there may well be a link between the severity of the enteropathy and the risk of developing malignancy.
Unlike CD, patients rarely have symptoms from the enteropathy and present with the characteristic intensely itchy rash. The standard treatment for DH is dapsone, which clears the rash within a matter of days. Consequently, many patients are treated by dermatologists with dapsone alone and a GFD is not recommended. In addition, many dermatologists seem unaware of the length of time required to control the rash (mean 2 years 4 months) and gastroenterologists seem unaware that in DH patients with no macroscopic abnormality of the small intestine, the rash is still gluten dependent and clears with a GFD (Reunala et al. 1977 , Fry et al. 1982 . Thus a normal macroscopic small intestinal mucosa on biopsy does not preclude treatment with a GFD. The enteropathy in DH may be patchy and a raised intraepithelial lymphocyte count (over 250/1000 epithelial cells) is a more sensitive indicator of gluten sensitivity. The lymphocyte count is almost invariably raised in the presence of a macroscopic enteropathy. However, in our series 2 of the 3 patients who went on to develop lymphomas had paradoxically low counts at presentation. This observation has been made independently by Ferguson et al. (1974) in coeliac patients with lymphoma, and possibly represents another pointer to patients at risk. It would seem from our findings that patients with a severe enteropathy, i.e. those with a macroscopically apparent abnormality of the small intestinal mucosa, should be encouraged to take a GFD, and we feel that all patients with DH should have a small intestinal biopsy at a centre familiar with the enteropathy encountered in DH.
A point which gastroenterologists have asked about CD is whether a GFD protects the patient against the development of lymphoma. An initial report (Harris et al. 1967) suggested that a GFD did appear to afford such protection; however, a later study (Holmes et al. 1976 ) did not support this finding, reporting 4 deaths from lymphoma in 134 patients taking a GFD, and 4 of 70 taking a normal diet, which represented a significant increase over those expected, but failed to show a statistically significant difference between the two dietary groups. In our study of DH patients, 6 of7 malignancies occurred in 70 patients taking a normal diet, whereas only one patient of 39 developed malignancy whilst taking a GFD. Thus there is a suggestion that a GFD may protect against lymphoma in DH patients. If this is substantiated, it has important implications in the management of patients with DH. Dermatologists would be obliged to investigate their patients more thoroughly than many do at present, and recommend treatment with a GFD, particularly in patients with a severe enteropathy. However, we appreciate from experience in our DH clinic that GFD is not an easy diet to follow, and many patients find it difficult and prefer simply to take dapsone for relief of their rash.
Why should DH patients have an increased incidence of malignancy? The increased risk of lymphoma in patients with a gluten-sensitive Journal of the Royal Society of Medicine Volume 76 February 1983 97 enteropathy does not necessarily imply that either gluten or the damaged mucosa itself is the predisposing factor to malignant change. Small intestinal damage in gluten sensitivity may be an expression of altered immunocompetence in these patients, which could predispose to malignant change. It may be relevant that in our patients with linear IgA disease, which has not been shown to be gluten-sensitive (Leonard et al. 1982) , there is some evidence that these patients also have an increased incidence of malignancy, including lymphomas. It is likely, therefore, that there is another factor involved, common to both CD and DH. This may be a' genetically-determined immunological defect which predisposes both to the development of the disease and to malignant change.Certainly, both patients with CD and DH share a very high incidence of the HLA-B8, DR3 genotype, which is associated with other diseases of disordered immunity.
Whatever the cause, DH must now be recognized as a skin disease carrying an increased susceptibility to the development of lymphomas and other tumours. From the available evidenceat present there seems every justification to recommend a GFD to all patients, and to be particularly persuasive in younger patients and those with a macroscopic enteropathy. Long-term
I-Jolistic medicine: a cooperative inquiry
The traditional view of the person is of a being of bOdy, mind and spirit. In ordinary language we often regard these components of the person as relatively separable. Thus we may talk of a 'healthy person', referring exclusively to the state of the person's body without regard to their mental and spiritual condition. Or we may speak of a 'holy person', bearing in mind their spiritual status without regard to their psychological or physical wellbeing.
Such usage does reflect some aspects of the' human condition: that body, mind and spirit can developa relative functional independence of each other; that to a degree and within certain limits ebach can flower without the other two being in full loom. A physically healthy person may be 0141-0768/83/020097-02/$01.00/0 follow up of DH patients whether taking a GFD or a normal diet in specialized clinics is important so that a definitive answer as to whether a GFD protects against malignancy can be obtained. W F G Tucker J N Leonard Lionel Fry
Dermatology Department Sf Mary's Hospital. London neither psychologically well integrated nor spiritually developed. A psychologically integrated person may lack the presence of evident spirituality and their health may be below par. And a holy person may show signs of psychological repression and lack of integration, as well as being physically ill.
It is the fact of functional independence that legitimates some degree of Cartesian dualism in practice. In medicine it is clearly appropriate within certain limits to regard the body, both aetiologically and therapeutically, as a relatively self-contained physical system, without addressing psychosocial and spiritual issues. Similarly, counsellors and psychotherapists may within certain limits deal with their clients' mental and emotional turmoil exclusively in terms of feelings, attitudes, meanings, intentions, without recourse to somatic factors or to spiritual activity.
